Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Patients who have been diagnosed with clinically isolated syndrome (CIS) often develop
problems related to the central nervous system, which controls the nerves in the body. Some
of these patients may later be diagnosed with multiple sclerosis (MS), a progressive disease
of the nervous system. The purpose of this study is to determine if the drug atorvastatin is
helpful to CIS patients.
Study hypothesis: Early intervention with atorvastatin in patients with CIS will result in a
state of immunological tolerance.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)